Canada· CA-DIN-02424991

MINT-HYDROXYCHLOROQUINE

A hydroxychloroquine product containing hydroxychloroquine sulfate, registered in Canada by MINT PHARMACEUTICALS INC. The same ATC class is registered in 17 of our 19 countries.

ATC P01BA02

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about hydroxychloroquine sulfateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Hydroxychloroquine is registered in 17 of 19 countries.

Countries holding a registration under ATC P01BA02 (hydroxychloroquine), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
10 of them publish a price we can compare per daily dose

Search hydroxychloroquine products by name

Hydroxychloroquine · ATC P01BA02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of hydroxychloroquine costs, country by country.

Normalised to the WHO defined daily dose (0.516 g), the median price runs from $0.33 in France to $1.28 in Switzerland — a ×3.9 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Hydroxychloroquine · price per daily dose (0.516 g)

USD · FX 28 Sept 2026

CH Switzerland$1.28
IT Italy$0.45
FR France$0.33

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: HYDROXYCHLOROQUINE SULFATE
Manufacturer: MINT PHARMACEUTICALS INC
Country: Canada (CA)
ATC code: P01BA02
ATC class: Hydroxychloroquine
Defined daily dose: 0.516 g, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

748 interactions on record for hydroxychloroquine.

Graded by severity as the source publishes them — 220 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check hydroxychloroquine against other medicines How interaction checks work

Hydroxychloroquine · interactions on record

748 records

220 severe
278 moderate
6 minor
244 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydroxychloroquine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxychloroquine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Hyplaxy
Belgium · Plaquenil
Bulgaria · Моривид
Cyprus · Plaquenil
Czechia · Plaquenil
Germany · Hydroxychloroquin Heumann, Hydroxychloroquin Ipca
Denmark · Pimaxiro, Plaquenil
Estonia · Hydroxychloroquine Auxilia, Plaquenil
Spain · Dolquine, Duplaxil
Finland · Oxiklorin
France · Plaquenil
United Kingdom (Northern Ireland) · Hydroxychloroquine Sulfate Accord-Uk, Hydroxychloroquine Sulfate Blackrock Pharmaceuticals
Greece · Plaquenil
Croatia · Hyplaxy
Hungary · Hidroxiklorokin Meditop, Plaquenil
Ireland · Plaquenil
Iceland · Plaquenil
Italy · Idrossiclorochina Aurobindo, Idrossiclorochina Doc
Lithuania · Plaquenil
Luxembourg · Plaquenil
Latvia · Plaquenil
Malta · Hydroxychloroquine Sulfate Ipca Laboratories Uk, Hydroxychloroquine Sulfate Ipca Produtos Farmaceuticos Unipessoal Lda
Netherlands · Hydroxychloroquine Sulfate Aurobindo, Hydroxychloroquinesulfaat Cf
Norway · Pimaxiro, Plaquenil
Poland · Autokila, Hydroquenin
Portugal · Hidroxicloroquina Basi, Hidroxicloroquina Generis
Romania · Hidroxiclorochina Atb, Plaquenil
Sweden · Pimaxiro, Plaquenil
Slovenia · Hyplaxy
Slovakia · Plaquenil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/2bf71bdd-6b4d-4300-83bd-359c60bb8900
GET /v1/drugs/2bf71bdd-6b4d-4300-83bd-359c60bb8900?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02424991",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "P01BA02",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "90966",
  "strengths": [
    "200 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "HYDROXYCHLOROQUINE SULFATE"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about hydroxychloroquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console